Thursday, 8 October 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Vaishali Pharma Ltd

NSE: VAISHALI · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹8.10
Market cap: ₹109.3 Cr
Revenue (annual): ₹108.8 Cr
Net profit (annual): ₹4.16 Cr
P/E (TTM): 24.7×Sector 47.3×
Promoter holding: 30.54%-1.07% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Annual General Meeting 4 Capital Structure Change 3 Board Meeting Date 3 Board Meeting Outcome 2 Price Movement Clarification 1 Management Change 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

14 Aug 2026 15:56 IST NSE

Financial Results

Vaishali Pharma Q1 FY27 Results: Net Profit ₹1.5 Cr, Up 15.4% YoY

Vaishali Pharma Ltd reported revenue from operations of ₹22.9 Cr (-3.4% YoY) and net profit of ₹1.5 Cr (+15.4% YoY) for Q1 FY27.

Key figure: Net profit ₹1.5 Cr · +15.4% YoY

Open full results → Read the filing ↗

30 May 2026 23:03 IST NSE

Financial Results

Vaishali Pharma Q4 FY26 Results: Net Profit ₹0.1 Cr, Down 92.3% QoQ

Vaishali Pharma Ltd reported revenue from operations of ₹26.9 Cr and net profit of ₹0.1 Cr for Q4 FY26.

Key figure: Net profit ₹0.1 Cr

Open full results → Read the filing ↗

30 May 2026 23:02 IST NSE

Financial Results

Vaishali Pharma Financial Results

Vaishali Pharma approved audited financial results for the year ended March 31, 2026. The board meeting concluded with the adoption of annual standalone and consolidated accounts.

Read the filing ↗

3 Apr 2026 17:55 IST BSE

Financial Results

Vaishali Pharma Q3 FY26 Results: Net Profit ₹1.3 Cr, Down 7.1% YoY

Vaishali Pharma Ltd reported net profit of ₹1.3 Cr (-7.1% YoY) for Q3 FY26.

Key figure: Net profit ₹1.3 Cr · -7.1% YoY

Open full results → Read the filing ↗